H2S-releasing latanoprost (CTG Pharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameH2S-releasing latanoprost (CTG Pharma)
Drug Alias NameACS-67
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid FP receptor agonists
TargetsProstanoid FP receptor
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCTG Pharma Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCTG Pharma Srl
Active IndicationsN/A
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A